BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 470342)

  • 1. Activation of the Hageman factor-prekallikrein system in the pathogenesis of the generalized Shwartzman reaction and of the hepatic vein thrombosis phenomenon in the rat.
    Latour JG; Groulx C; Léger-Gauthier C
    Lab Invest; 1979 Sep; 41(3):237-46. PubMed ID: 470342
    [No Abstract]   [Full Text] [Related]  

  • 2. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization to the generalized Shwartzman reaction by catechol-O-methyltransferase inhibitors.
    Latour JG; Láger-Gauthier C
    Am J Pathol; 1978 Aug; 92(2):377-87. PubMed ID: 677267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor.
    Silverberg M; Nicoll JE; Kaplan AP
    Thromb Res; 1980 Oct; 20(2):173-89. PubMed ID: 6908319
    [No Abstract]   [Full Text] [Related]  

  • 5. High prekallikrein levels during pregnancy.
    Marcel GA; Caspar C; Sabatier C; Gautray J; Schirar A
    Pathol Biol (Paris); 1975 Dec; 23 suppl():66-8. PubMed ID: 772561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation of prekallikrein from human blood serum by different activators].
    Iarovaia GA; Dotsenko VL; Krizhevskaia IuV; Morozova NA; Orekhovich VN
    Biokhimiia; 1979 Jul; 44(7):1279-85. PubMed ID: 497275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical material.
    Egberg N; Gallimore MJ
    Adv Exp Med Biol; 1983; 156 (Pt B)():1109-17. PubMed ID: 6552857
    [No Abstract]   [Full Text] [Related]  

  • 8. Hageman factor dependent activation and its relationship to lethal Pseudomonas aeruginosa burn wound infections.
    Holder IA; Neely AN
    Agents Actions Suppl; 1992; 38 ( Pt 3)():329-42. PubMed ID: 1462867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumption of Hageman factor activity in the generalized Shwartzman reaction induced by liquoid. Its prevention by inhibition of Hageman factor activation.
    Müller-Berghaus G; Lasch HG
    Thromb Diath Haemorrh; 1970 May; 23(2):386-404. PubMed ID: 5426216
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quarter century with Mr. Hageman.
    Ratnoff OD
    Thromb Haemost; 1980 Jun; 43(2):95-8. PubMed ID: 7006141
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prekallikrein activator (Hageman factor fragment) in human plasma fractions.
    Kuwahara SS
    Transfusion; 1980; 20(4):433-9. PubMed ID: 6773191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the activation of the pre-kininogenin-kininogenin (pre-kallikrein-kallikrein) system by sulfated polysaccharides and kaolin.
    dos Santos E; Rothschild HA; Rocha e Silva M
    Adv Biosci; 1978 Jul; 17():145-50. PubMed ID: 755691
    [No Abstract]   [Full Text] [Related]  

  • 15. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of factor XII and prekallikrein with cholesterol sulfate.
    Shimada T; Kato H; Iwanaga S; Iwamori M; Nagai Y
    Thromb Res; 1985 Apr; 38(1):21-31. PubMed ID: 3847226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
    Stürzebecher J; Huyke R; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):492-6. PubMed ID: 6083916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular coagulation, hyperlipemia, and fat embolism: their association during the generalized Shwartzman phenomenon in rabbits.
    Allardyce DB; Groves AC
    Surgery; 1969 Jul; 66(1):71-9. PubMed ID: 4892314
    [No Abstract]   [Full Text] [Related]  

  • 20. A new prekallikrein activator in human plasma which differs from Hageman factor and its fragments.
    Webster ME; Stella RC; Villa ML; Toffoletto O
    Adv Exp Med Biol; 1979; 120B():53-9. PubMed ID: 517247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.